AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 130 filers reported holding AMPIO PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | -100.0% | 10,890 | +39.8% | 0.00% | – |
| Q2 2022 | $1,000 | -75.0% | 7,790 | 0.0% | 0.00% | – |
| Q1 2022 | $4,000 | 0.0% | 7,790 | 0.0% | 0.00% | – |
| Q4 2021 | $4,000 | -69.2% | 7,790 | 0.0% | 0.00% | – |
| Q3 2021 | $13,000 | 0.0% | 7,790 | 0.0% | 0.00% | – |
| Q2 2021 | $13,000 | -23.5% | 7,790 | -20.4% | 0.00% | – |
| Q1 2021 | $17,000 | +41.7% | 9,790 | +25.7% | 0.00% | – |
| Q4 2020 | $12,000 | +71.4% | 7,790 | 0.0% | 0.00% | – |
| Q3 2020 | $7,000 | +40.0% | 7,790 | 0.0% | 0.00% | – |
| Q2 2020 | $5,000 | +66.7% | 7,790 | 0.0% | 0.00% | – |
| Q1 2020 | $3,000 | -40.0% | 7,790 | 0.0% | 0.00% | – |
| Q4 2019 | $5,000 | +25.0% | 7,790 | 0.0% | 0.00% | – |
| Q3 2019 | $4,000 | +33.3% | 7,790 | 0.0% | 0.00% | – |
| Q2 2019 | $3,000 | -25.0% | 7,790 | 0.0% | 0.00% | – |
| Q1 2019 | $4,000 | +33.3% | 7,790 | 0.0% | 0.00% | – |
| Q4 2018 | $3,000 | – | 7,790 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 5,265,265 | $2,042,000 | 2.57% |
| Cypress Capital Management LLC (WY) | 288,225 | $112,000 | 0.13% |
| Harvest Investment Services, LLC | 109,443 | $45,000 | 0.03% |
| Noven Financial Group, Inc. | 123,772 | $48,000 | 0.02% |
| COURIER CAPITAL LLC | 379,973 | $147,000 | 0.02% |
| Valeo Financial Advisors, LLC | 330,000 | $128,000 | 0.02% |
| STEEL GROVE CAPITAL ADVISORS, LLC | 55,500 | $22,000 | 0.01% |
| Transform Wealth, LLC | 205,481 | $80,000 | 0.01% |
| Strategic Financial Services, Inc. | 140,000 | $54,000 | 0.01% |
| Traynor Capital Management, Inc. | 48,562 | $20,000 | 0.01% |